机构:[1]Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China首都医科大学附属北京同仁医院医技科室核医学科[2]Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China[3]Cardiovascular Institute & Fu Wai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100037, China[4]State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
Tc-99m-3P-RGD2 and SPECT/CT were valuable tools for selecting patient likely benefit from integrin alpha (v) beta (3) blocking therapy. To evaluate the feasibility of Tc-99m-3P-RGD2 imaging to detect head and neck squamous cell carcinoma, Tc-99m-3P-RGD2 was prepared and the relationship between its accumulation and integrin alpha (v) beta (3) expression in nude mice bearing HEP-2 or CNE-1 carcinoma xenograft were analyzed. This study demonstrated that Tc-99m-3P-RGD2, with high affinity to integrin alpha (v) beta (3), will provide basis for alpha (v) beta (3) involved individual therapy.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91229127, 81071176]; Basic-Clinical Cooperation foundation of Capital Medical University [12JL88]
第一作者机构:[1]Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
通讯作者:
通讯机构:[2]Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China
推荐引用方式(GB/T 7714):
Yan Bing,Qiu Fan,Ren Ling,et al.Tc-99m-3P-RGD2 molecular imaging targeting integrin alpha (v) beta (3) in head and neck squamous cancer xenograft[J].JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY.2015,304(3):1171-1177.doi:10.1007/s10967-015-3928-5.
APA:
Yan, Bing,Qiu, Fan,Ren, Ling,Dai, Haojie,Fang, Wei...&Wang, Feng.(2015).Tc-99m-3P-RGD2 molecular imaging targeting integrin alpha (v) beta (3) in head and neck squamous cancer xenograft.JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY,304,(3)
MLA:
Yan, Bing,et al."Tc-99m-3P-RGD2 molecular imaging targeting integrin alpha (v) beta (3) in head and neck squamous cancer xenograft".JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY 304..3(2015):1171-1177